Skip to content

Risk Factors of liver disease in the family of Liver disease patient.

Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC).

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020780
Enrollment
1494
Registered
2019-08-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified Health Condition 2: K769- Liver disease, unspecified

Interventions

Sponsors

Institute of Liver and Biliary Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed cases of NASH with Cirrhosis. 2. Age >= 8 year 3. All the first degree relatives of NRC i.e index case. 4. Subject with no history of any known liver disease 5. Non-Alcoholic 6. Matched with age (+/-5 years) and gender

Exclusion criteria

Exclusion criteria: 1. Acute on Chronic Liver Failure 2. Patients with HBV, HCV, Wilson, Hemochromatosis, alpha 1 antitrypsin deficiency, primary biliary cirrhosis). 3. Patient on amiodarone or tamoxifen or methotrexate. 4. Patient of malignancies other than liver. 5. Patient on chemotherapy 6. HBV related Liver Fibrosis (<= F3).

Design outcomes

Primary

MeasureTime frame
Assessment of the risk factors for liver fibrosis among the first degree relatives of NASH related CirrhosisTimepoint: 0 day

Secondary

MeasureTime frame
Assessment of the risk factors in patients with NASH related cirrhosis and Hepatitis B Virus Control.Timepoint: 0 day;Assessment of the risk factors in patients with NASH related Cirrhosis and their Healthy Control.Timepoint: 0 day;To assess the Genetic Single Nucleotide Polymorphism in NASH related Cirrhosis patients and their first degree relatives.Timepoint: 0 day;To assess the proportion of Liver fibrosis among first degree relatives of patients with NASH related Cirrhosis.Timepoint: 0 day

Countries

India

Contacts

Public ContactDr Ankit Bhardwaj

Institute of Liver and Biliary Sciences

umeshkapil@gmail.com01146300000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026